Table 2. Baseline characteristics of controls and FH+ and FH- patients.
| FH+ patients (n = 88) | FH- patients (n = 180) | Controls (n = 237) | Statistic | ||
|---|---|---|---|---|---|
| Sex | Female | 30 (34.1%) | 54 (30%) | 84 (35.4%) | X2 = 1.75, P = 0.417 |
| Age | 24.17 (5.75) | 23.47 (5.80) | 24.33 (6.43) | F = 1.83, P = 0.161 | |
| Educational level | Primary education | 19 (21.6%) | 41 (22.8%) | 17 (7.2%) | X2 = 60.74, P<0.001 |
| Secondary education | 57 (64.8%) | 112 (62.2%) | 119 (50.2%) | ||
| University | 12 (13.6%) | 27 (15%) | 101 (42.6%) | ||
| Civil status | Single | 73 (83%) | 162 (90%) | 200 (84.4%) | X2 = 2.48, P = 0.242 |
| Married | 6 (6.9%) | 11 (6.1%) | 19 (8.2%) | ||
| Other | 9 (10.2%) | 7 (3.9%) | 18 (7.6%) | ||
| Occupation | Working | 17 (19.5%) | 23 (12.8%) | 109 (46%) | X2 = 94.85, P<0.001 |
| Student | 39 (44.8%) | 80 (44.4%) | 109 (46%) | ||
| Other | 31 (35.6%) | 77 (42.8%) | 19 (8%) | ||
| Current alcohol use | Yes | 39 (48.2%) | 81 (47.9%) | 145 (65%) | X2 = 13.91, P = 0.001 |
| Current tobacco use | Yes | 58 (68.2%) | 108 (63.5%) | 77 (34.8%) | X2 = 43.64, P<0.001 |
| Current cannabis use | Yes | 34 (38.6%) | 73 (43.2%) | 37 (16.6%) | X2 = 37.25, P<0.001 |
| Estimated premorbid IQ | 91.53 (16.56) | 92.86 (14.64) | 107.48 (14.18) | F = 66.37, P<0.001 | |
| Antipsychotic dose (mg/day) | 592.84 (476.27) | 550.26 (431.72) | NA | t = -0.73, p = 0.467 |